Studies on Molecular Mechanisms of Translesion Synthesis and Carcinogenesis

跨损伤合成及癌变的分子机制研究

基本信息

  • 批准号:
    12213070
  • 负责人:
  • 金额:
    $ 43.26万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2004
  • 项目状态:
    已结题

项目摘要

In order to understand the molecular mechanisms of translesion synthesis and the relationships between carcinogenesis and translesion synthesis, we studied various aspects of translesion synthesis with special reference on human DNA polymerase η (Pol η) and obtained following results.1. Human Pol η copies undamaged DNA with much lower fidelity than any other template-dependent DNA polymerase studied. On the other hand, human Pol η catalyzes efficient and accurate translesion synthesis past cic-syn cyclobutane di-thymine lesions, AAF-modified guanine, and a cisplatin-induced intrastrand cross-link between two guanines.2. Human Pol η gene consists of 11 exons covering the entire coding region of the transcription-initiation, and the genomic DNA analysis suggested that three of four XP-V cell lines have homozygous mutations, and one of them have heterozygous point mutations, one of which is a splice mutation of the major allele.3. Human Pol η binds template/primer DNAs regardless of TT dimers. Rather, enhanced binding to template/primer DNAs containing TT dimers is only observed when the 3-end of the primer is an adenosine residue situated opposite the lesion. When two nucleotides have been incorporated into the primer beyond the TT dimer position, the Pol η-template/primer DNA complex is destabilized.4. In order to make a good in vivo model to study the high incidence of skin carcinogenesis in XP-V patients, we disrupted the mouse Pol η gene in ES cells by replacing exon 8 with the neo^r gene. Mice that are homozygous for the null mutation are viable, fertile and did not show any obvious defects during their first year of life. Pol η-deficient fibroblasts derived from the mutant mice have reduced capacity to replicate UV-damaged DNA. Pol η-deficient mice developed skin tumors after UVB-irradiation, while wild-type and heterozygous littermates did not.
为了了解跨损伤合成的分子机制以及肿瘤发生与跨损伤合成的关系,我们以人DNA聚合酶η(Pol η)为研究对象,对跨损伤合成的各个方面进行了研究,并获得了以下结果.人类Pol η复制未受损DNA的保真度比任何其他研究的模板依赖性DNA聚合酶低得多。另一方面,人Pol η催化通过环合环丁烷二胸腺嘧啶损伤、AAF修饰的鸟嘌呤和顺铂诱导的两个鸟嘌呤之间的链内交联的有效且准确的跨损伤合成。人Pol η基因由11个外显子组成,覆盖了转录起始的整个编码区,基因组DNA分析表明,4个XP-V细胞系中有3个存在纯合突变,1个存在杂合点突变,其中1个为主要等位基因的剪接突变.人Pol η结合模板/引物DNA,而不管TT二聚体。相反,只有当引物的3-末端是位于病变对面的腺苷残基时,才观察到与含有TT二聚体的模板/引物DNA的结合增强。当两个核苷酸已经掺入引物中超过TT二聚体位置时,Pol η-模板/引物DNA复合物不稳定。为了研究XP-V患者皮肤癌发生率高的体内模型,我们通过用neo^r基因替换小鼠ES细胞中的Pol η基因的外显子8来破坏小鼠Pol η基因。对于无效突变纯合的小鼠是可存活的、可繁殖的,并且在它们生命的第一年期间没有显示出任何明显的缺陷。来自突变小鼠的Pol η缺陷型成纤维细胞复制UV损伤DNA的能力降低。Pol η缺陷小鼠在UVB照射后发生皮肤肿瘤,而野生型和杂合子同窝出生的小鼠则没有。

项目成果

期刊论文数量(82)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
DNA binding properties of human DNA polymerase η : Implication for polymerase switching.
人类 DNA 聚合酶的 DNA 结合特性 η:对聚合酶转换的影响。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kusurnoto;R.;Masutani;C.;et al.
  • 通讯作者:
    et al.
Bassett E. et al.: "Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin by human DNA polymerases β and η"Biochemistry. 42. 14197-14206 (2003)
Bassett E. 等人:“通过人类 DNA 聚合酶 β 和 η 延伸错配引物末端的效率”生物化学 42. 14197-14206 (2003)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada, A.et al.: "Detection of reduced RNAsynthesis in UV-irradiated Cockayne syndrome B cells using an isolated nuclear system"Biochim.Biophys.Acta. 1592. 129-134 (2002)
Yamada, A.等人:“使用分离的核系统检测紫外线照射的科凯恩综合征 B 细胞中 RNA 合成减少”Biochim.Biophys.Acta。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Servanit, L.et al.: "A role for DNA polymerase β in mutagenic UV lesions bypass"J.Biol.Chem.. 277. 50046-50053 (2002)
Servanit, L. 等人:“DNA 聚合酶 β 在诱变紫外线损伤绕过中的作用”J.Biol.Chem.. 277. 50046-50053 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Interaction of hREV1 with three human Y-family DNA polymerases
  • DOI:
    10.1111/j.1356-9597.2004.00747.x
  • 发表时间:
    2004-06-01
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Ohashi, E;Murakumo, Y;Ohmori, H
  • 通讯作者:
    Ohmori, H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HANAOKA Fumio其他文献

Relevance of simultaneous mono-ubiquitinations of multiple units of PCNA homo-trimers in DNA damage torelance.
PCNA 同源三聚体多个单位同时单泛素化与 DNA 损伤耐受性的相关性。
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    MASUTANI Chikahide;KANAO Rie;MASUDA Yuji;HANAOKA Fumio
  • 通讯作者:
    HANAOKA Fumio
日本南北朝期古記録テキストを用いた潜在的トピックの検出と時系列変化
使用日本南北町时代的旧记录检测潜在主题和时间变化

HANAOKA Fumio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HANAOKA Fumio', 18)}}的其他基金

Study on rapid and hypersensitive screening of chemical genotoxin using mammalian cells defective for DNA damage-response factors
利用 DNA 损伤反应因子缺陷的哺乳动物细胞快速、超灵敏筛查化学基因毒素的研究
  • 批准号:
    15K14953
  • 财政年份:
    2015
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Functional analyses and development of inhibitors based on higher-order structure of translesion DNA polymerase eta
基于跨损伤DNA聚合酶eta高阶结构的功能分析和抑制剂开发
  • 批准号:
    15H04646
  • 财政年份:
    2015
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analyses of functional roles of TLS polymerases using transgenic mice
使用转基因小鼠分析 TLS 聚合酶的功能作用
  • 批准号:
    22249005
  • 财政年份:
    2010
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Cellular responses to inhibition of DNA replication fork progression at DNA lesions
DNA 损伤时细胞对 DNA 复制叉进展抑制的反应
  • 批准号:
    19209003
  • 财政年份:
    2007
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of translesion DNA synthesis and its involvement in carcinogenesis
跨损伤DNA合成的分子机制及其参与致癌作用
  • 批准号:
    17013053
  • 财政年份:
    2005
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
STUDY ON NOVEL REQULATORY MECHANISMA OF DNA REPAIR
DNA修复新调节机制的研究
  • 批准号:
    13308041
  • 财政年份:
    2001
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Mechanisms of Genomic Instability and DNA Repair
基因组不稳定性和DNA修复的分子机制
  • 批准号:
    08280103
  • 财政年份:
    1996
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (A)
Search for Novel Anti-cancer Drugs Targetting DNA Replication and Repair
寻找针对 DNA 复制和修复的新型抗癌药物
  • 批准号:
    08557131
  • 财政年份:
    1996
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Mechanisms of DNA Damage Recoguition and Repair
DNA损伤识别与修复的分子机制
  • 批准号:
    08407072
  • 财政年份:
    1996
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study on Structure and Function of Mammalian DNA Replication Entyme
哺乳动物DNA复制酶结构与功能的研究
  • 批准号:
    04454598
  • 财政年份:
    1992
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
  • 批准号:
    10634852
  • 财政年份:
    2023
  • 资助金额:
    $ 43.26万
  • 项目类别:
Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells
人类细胞中 Y 家族 DNA 聚合酶高保真度跨损伤合成的机制
  • 批准号:
    10550540
  • 财政年份:
    2023
  • 资助金额:
    $ 43.26万
  • 项目类别:
Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers
靶向跨损伤合成途径作为化疗耐药和晚期癌症的潜在治疗策略
  • 批准号:
    495243
  • 财政年份:
    2023
  • 资助金额:
    $ 43.26万
  • 项目类别:
Mechanistic insights into translesion synthesis-dependent genome instability
对跨损伤合成依赖的基因组不稳定性的机制见解
  • 批准号:
    10714421
  • 财政年份:
    2023
  • 资助金额:
    $ 43.26万
  • 项目类别:
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
组蛋白 H4 LRS 突变对跨损伤合成和 UV 诱变的影响
  • 批准号:
    10353127
  • 财政年份:
    2021
  • 资助金额:
    $ 43.26万
  • 项目类别:
Combatting Antimicrobial Resistance using a Translesion Synthesis Complex
使用跨损伤合成复合物对抗抗菌素耐药性
  • 批准号:
    565623-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
组蛋白 H4 LRS 突变对跨损伤合成和 UV 诱变的影响
  • 批准号:
    10532160
  • 财政年份:
    2021
  • 资助金额:
    $ 43.26万
  • 项目类别:
Mutagenesis by translesion synthesis bypass endogenous DNA structures by DNA polymerase zeta
DNA聚合酶zeta通过跨损伤合成绕过内源DNA结构进行诱变
  • 批准号:
    20K12181
  • 财政年份:
    2020
  • 资助金额:
    $ 43.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy
抑制跨损伤合成作为癌症化疗的新策略
  • 批准号:
    10188462
  • 财政年份:
    2019
  • 资助金额:
    $ 43.26万
  • 项目类别:
Inhibition of Translesion Synthesis as a Novel Strategy for Cancer Chemotherapy
抑制跨损伤合成作为癌症化疗的新策略
  • 批准号:
    10398128
  • 财政年份:
    2019
  • 资助金额:
    $ 43.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了